2022
DOI: 10.1128/mra.01072-21
|View full text |Cite
|
Sign up to set email alerts
|

Draft Hybrid Genome Assembly of a Canadian Cyclospora cayetanensis Isolate

Abstract: The apicomplexan parasite Cyclospora cayetanensis causes foodborne gastrointestinal disease in humans. Here, we report the first hybrid assembly for C. cayetanensis , which uses both Illumina MiSeq and Oxford Nanopore Technologies MinION platforms to generate genomic sequence data. The final genome assembly consists of 44,586,677 bases represented in 313 contigs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 10 publications
0
4
0
Order By: Relevance
“…In order to improve the genotyping ability of the TADS scheme, novel markers that display a greater sequencing success rate and higher entropy should replace the least sensitive and discriminatory markers, Nu_CDS1, Nu_CDS2, and Nu_CDS4. Research should focus on identifying new markers through comparative analyses of whole genome sequences available to date, including the newly published hybrid assembly of a Canadian C. cayetanensis isolate [24] and four other Canadian genomes generated (unpublished). Additionally, comparative analyses should focus on finding discriminatory markers that further differentiate the isolates that are grouping into persistent clusters observed over several years.…”
Section: Discussionmentioning
confidence: 99%
“…In order to improve the genotyping ability of the TADS scheme, novel markers that display a greater sequencing success rate and higher entropy should replace the least sensitive and discriminatory markers, Nu_CDS1, Nu_CDS2, and Nu_CDS4. Research should focus on identifying new markers through comparative analyses of whole genome sequences available to date, including the newly published hybrid assembly of a Canadian C. cayetanensis isolate [24] and four other Canadian genomes generated (unpublished). Additionally, comparative analyses should focus on finding discriminatory markers that further differentiate the isolates that are grouping into persistent clusters observed over several years.…”
Section: Discussionmentioning
confidence: 99%
“…Despite such limitations, researchers studying limited supplies of C. cayetanensis have made commendable progress characterizing strains, genomes, and advancing detection. Several C. cayetanensis draft genomes have been characterized and published [ 3 , 4 , 5 , 6 , 7 , 8 , 9 ] and molecular typing efforts have given rise to powerful genotyping tools [ 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 ] for epidemiological analysis, such as outbreak tracing. As described below, methods such as these and others are now being used to detect C. cayetanensis from various sources of infection.…”
Section: The Scarcity Of Oocysts Slows Research Progressmentioning
confidence: 99%
“…The first published draft genome sequence for C. cayetanensis , reported by Qvarnstrom et al (2015) [ 4 ] provided an assembly consisting of ~44 Mb, including a full-length mitochondrial genome of ~6.3 Kb and an apicoplast genome of ~24 Kb. Since then, advances in Next Generation Sequencing (NGS) technologies and bioinformatics have fostered additional draft genome assemblies, complete mitochondrial and apicoplast genomes of C. cayetanensis [ 3 , 5 , 6 , 7 , 8 , 9 , 10 , 57 ]. Several other studies have made strides on C. cayetanensis genomics and diagnostics, focusing on genotyping assays for use with stool and produce samples and molecular techniques to improve detection and sequencing (also cited above).…”
Section: What Can We Learn From Such Surrogates?mentioning
confidence: 99%
“…There are no known methods of propagating C. cayetanensis in the laboratory, and it is time-consuming and difficult to isolate oocysts from clinical specimens; thus, whole genome sequencing is not a practical option for determining genetic linkages among specimens [12,13]. The U.S. Centers for Disease Control and Prevention (CDC) has been implementing a multi-locus sequence typing (MLST) scheme to genetically cluster C. cayetanensis clinical fecal specimens to supplement epidemiologic information when investigating outbreaks [14].…”
Section: Introductionmentioning
confidence: 99%